Gilead CMO exercises RSUs, covers taxes with shares
Gilead Sciences Chief Medical Officer Dietmar Berger reported routine equity compensation activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences Chief Medical Officer Dietmar Berger reported routine equity compensation activity. On June 10, 2026, he exercised 533 restricted stock units, converting them into the same number of Gilead common shares at an exercise price of $0.00 per share.
To cover associated tax obligations, 263 common shares were disposed of at $121.48 per share through a tax-withholding transaction, which is not an open-market sale. Following these transactions, he directly holds 19,252 shares of common stock and 46,928 restricted stock units, which continue to vest over a four-year schedule.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 533 | $0.00 | $0.00 |
| Exercise | Common Stock | 533 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 263 | $121.48 | $32K |
Footnotes (2)
- F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Key Figures
Key Terms
Restricted Stock Unit financial
4-year vesting schedule financial
tax-withholding disposition financial
derivative security financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Gilead (GILD) executive Dietmar Berger report in this Form 4?
How many restricted stock units did Dietmar Berger convert at Gilead (GILD)?
What are Dietmar Berger’s Gilead (GILD) holdings after these transactions?
How do Dietmar Berger’s Gilead (GILD) restricted stock units vest over time?
Does this Gilead (GILD) Form 4 show open-market buying or selling by Dietmar Berger?
AI-generated analysis. How Rhea-AI works. Not financial advice.